Myriad Genetics (MYGN) Invested Capital (2016 - 2025)

Myriad Genetics (MYGN) posted quarterly Invested Capital of $59.4 million for Q2 2025, down 42.94% quarter-over-quarter from $104.1 million in Q2 2021.

Myriad Genetics (MYGN) Invested Capital (2016 - 2025) Analysis & Trends

Myriad Genetics (MYGN) has reported Invested Capital for 7 consecutive years, with $59.4 million the latest figure, recorded in Q2 2025.

  • In Q2 2025, Invested Capital changed N/A year-over-year to $59.4 million; the TTM figure through Mar 2026 stood at $59.4 million (changed N/A YoY), while the FY2020 annual figure was $3.1 million, down 8.82% from the prior year.
  • Invested Capital declined to $59.4 million in Q2 2025 per MYGN's latest filing, from $104.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $104.1 million in Q2 2021 and bottomed at $59.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Thermo Fisher Scientific 213.44 Bn 209.37 Bn 8.34 Bn 3.37 Bn
2 Danaher 139.95 Bn 135.60 Bn 3.61 Bn 1.41 Bn
3 Idexx Laboratories 46.16 Bn 45.96 Bn 779.09 Mn 519.00 Mn
4 Agilent Technologies 39.67 Bn 37.87 Bn 990.00 Mn 304.00 Mn
5 Iqvia Holdings 39.29 Bn 37.21 Bn 1.44 Bn 2.29 Bn
6 Natera 38.61 Bn 37.51 Bn 696.04 Mn 22.35 Mn
7 Illumina 29.99 Bn 28.82 Bn 770.00 Mn -
8 Mettler Toledo International 28.57 Bn 28.51 Bn 650.22 Mn 67.29 Mn
9 Quest Diagnostics 26.17 Bn 25.55 Bn 1.03 Bn 10.00 Mn
10 Myriad Genetics 296.09 Mn 171.69 Mn 137.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 59.40 Mn
Jun 30, 2021 104.10 Mn
Sep 30, 2020 3.30 Mn
Jun 30, 2020 3.10 Mn
Mar 31, 2020 3.10 Mn
Dec 31, 2019 3.40 Mn
Sep 30, 2019 3.30 Mn
Jun 30, 2019 3.40 Mn
Mar 31, 2019 3.70 Mn
Dec 31, 2018 5.30 Mn
Sep 30, 2018 5.30 Mn
Jun 30, 2018 5.30 Mn
Mar 31, 2018 7.40 Mn
Dec 31, 2017 70.00 Mn
Sep 30, 2017 75.10 Mn
Jun 30, 2017 100.00 Mn
Mar 31, 2017 168.10 Mn
Dec 31, 2016 205.00 Mn
Sep 30, 2016 199.20 Mn